LUFAX (06623) may delay the publication of its 2024 annual performance.

LUFAX (06623) announced that as of the date of this announcement, the independent investigation is still ongoing. The independent investigation is currently expected to be completed in mid-April 2025, after which the company will disclose the main investigation results and any further actions (if any) planned regarding the transactions mentioned. As of the date of this announcement, the Audit Committee is evaluating candidates for the successor auditor of the company. Once the appointment is approved by shareholders at the shareholders' meeting, the company will collaborate with the successor auditor to audit the financial reports of the company for the years ending December 31, 2022, 2023, and 2024, based on the successor auditor's opinions and acceptance procedures. A separate announcement will be made after selecting the successor auditor. Due to the time required for the successor auditor to complete the audit work, there may be a delay in the publication of the 2024 annual performance of the company. LUFAX is a dual-listed company in the US and Hong Kong. As of the last trading day, the closing price of the US stock was $2.90 with a trading volume of 2.96 million ADS, and overall trading volume remained stable.